ALVO: Alvotech Corp Company Value to Net Income

Corporate emblem and logo of Alvotech S.A. (ALVO)

Alvotech's volatile cash flows are driven by the anticipation of regulatory decisions and patent resolutions. The issuer's P/E chart illustrates the market valuation of earnings, where the value -9.50 captures the metric level. The business foundation is built upon state-of-the-art plant capacities with ideal equipment and a commitment to ESG principles aimed at sustainable production and the accessibility of biosimilars.

ALVO Alvotech Biopharmaceuticals: Price to Earnings Ratio in the range 04/28/2023 - 11/10/2026

Comprehensive metric breakdowns and analytics for Alvotech Corp (ALVO)

- price and consensus price forecast:
Stock Price alvotech.com|ALVO - Consensus Target
- market capitalization information:
Market Value Alvotech SA|ALVO - Total Company Value
- balance sheet net asset value indicators:
Net Asset Value per Share Alvotech|ALVO - Company Net Assets|Market Cap to Book Value Multiple alvotech.com|ALVO - Company Total Assets
- company liabilities and liquidity data:
All Debt to Shareholders' Equity Ratio Alvotech|ALVO - Long-Term Debt to Capital|Current Liabilities to Capital Alvotech Biopharmaceuticals|ALVO - Company Debts|Debt to Net Assets Ratio Alvotech SA|ALVO - Company Long-Term Debts|Company Short-Term Debts Alvotech|Quick Liquidity alvotech.com
- business earnings and investment ratios data:
ALVO - Net Income|Expected Profit Alvotech|ALVO - Price to Earnings Ratio|Projected Price to Earnings Ratio Alvotech S.A.|ALVO - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Alvotech SA|ALVO - Operating profit EBITDA|Net earnings per one share for the last twelve months Alvotech|ALVO - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months alvotech.com|ALVO - Earnings growth in current year|Expected earnings per share trend next year Alvotech
Comprehensive company analysis:alvotech.com - ALVO
Flagship merchandise of Alvotech SA

The P/E ratio measures the market value of a single unit of profit, reflecting investors' willingness to pay a premium for the company's future cash flows. By analyzing the annual P/E of Alvotech (ALVO), one can assess the fairness of the valuation, given that long-term demand for biosimilars via government formularies ensures stable rent and mitigates asset value volatility risks.

Key competitors

P/E Multiple haleon.com|Price to Earnings Ratio KVUE (Kenvue)|VRNA (Verona Pharma PLC) - Company Value to Net Income|Price to Earnings Ratio Jyong Biotech Corp MENS|Ligand Corp (LGND) - Market Cap to Earnings|AMRX: Price to Earnings Ratio|perrigo.com - Market Price to Net Income Ratio|LQDA: P/E Multiple|Galapagos N.V. - Company Value to Net Income|ANIP (ANI Pharma) - P/E Multiple|Market Cap to Earnings Afrezza MNKD|Price to Earnings Ratio Amphastar Pharmaceuticals (AMPH)|PCRX (pacira.com) - Company Value to Net Income|P/E Multiple SPRY (ARS Pharmaceuticals, Inc.)|P/E Multiple Theravance Biopharma Inc TBPH|AQST - Price to Earnings Ratio|SCPH: Price to Earnings Ratio|TECX (tectonictx.com) - Price to Earnings Ratio|TNXP (tonixpharma.com) - Price to Earnings Ratio|Price to Earnings Ratio SXT Pharmaceuticals|Market Cap to Earnings Eupraxia Pharma EPRX|Price to Earnings Ratio BHST (BioHarvest)|Market Price to Net Income Ratio EXOZ|P/E Multiple ORMP (Oramed Pharmaceuticals Inc.)|Entera Bio Ltd (ENTX) - Market Cap to Earnings|MindWalk Holdings Inc. - P/E Multiple|ABVC BioPharma Inc. (ABVC) - Price to Earnings Ratio|CPIX: P/E Multiple|Quantum BioPharma Corp - Company Value to Net Income|FGEN (FibroGen, Inc.) - P/E Multiple|P/E Multiple telomirpharma.com|Price to Earnings Ratio Rani Therapeutics (RANI)|Price to Earnings Ratio SNYR (synergychc.com)|Rallybio - Price to Earnings Ratio|Lexaria Bioscience Corp - Price to Earnings Ratio|PULM - Price to Earnings Ratio|Market Cap to Earnings Pheton Holdings Ltd|aptorumgroup.com (APM) - Price to Earnings Ratio|Market Cap to Net Income LYRA (Lyra Therapeutics Inc.)|IBO (Impact BioMedical) - P/E Multiple|TNFA: Company Value to Net Income|P/E Multiple YCBD|P/E Multiple painreform.com (PRFX)|Price to Earnings Ratio Altamira Therapeutics Ltd. CYTO|Company Value to Net Income LIPO|OPTN - Price to Earnings Ratio|Pieris Pharma (PIRS) - Price to Earnings Ratio|PROC: P/E Multiple|petrospharma.com (PTPI) - P/E Multiple|Price to Earnings Ratio QLI|SLRN: Company Value to Net Income|Price to Earnings Ratio TFF Pharma (TFFP)